(b)
where a third party provides goods and services that affect tissue or cell quality and safety assurance, including their distribution;
← (a) · All articles · (c) →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.